Ourotech's CEO Duleeka Ranatunga presented their novel cancer drug screening technology at the WSJ.D Conference last week.
Their pitch is featured on the Wall Street Journal website here
Advanced Code injection
Ourotech's CEO Duleeka Ranatunga presented their novel cancer drug screening technology at the WSJ.D Conference last week.
Their pitch is featured on the Wall Street Journal website here